<DOC>
	<DOC>NCT00002119</DOC>
	<brief_summary>To evaluate the clinical toxicity, safety, and MTD of WF 10 ( TCDO ) intravenous solution administered to patients with HIV infection. To evaluate the potential anti-HIV activity of TCDO.</brief_summary>
	<brief_title>A Phase I/II Clinical Study of WF 10 IV Solution ( TCDO ) in Patients With HIV Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication: Required: Aerosolized pentamidine (300 mg monthly) as prophylaxis for PCP only in patients with CD4 count &lt;= 200 cells/mm3. Allowed: PCP prophylaxis with aerosolized pentamidine in patients with CD4 count &gt; 200 cells/mm3, only at the discretion of the treating physician. Patients must have: HIV positivity. Absolute CD4 count of 150 500 cells/mm3. At least 6 months of prior zidovudine therapy. No active opportunistic infection requiring ongoing therapy. Life expectancy of at least 6 months. Exclusion Criteria Coexisting Condition: Patients with the following symptoms or conditions are excluded: Neoplasm other than basal cell carcinoma of the skin. Clinically significant cardiac disease. Abnormal neurological status by a standardized assessment including strength, reflex testing, and sensory testing. Unwilling to comply with protocol requirements. Patients with the following prior conditions are excluded: History of myocardial infarction or arrhythmias. Prior Medication: Excluded within 2 weeks prior to study entry: Antiretroviral agent or interferon. Systemic biologic response modifiers, corticosteroids, cytotoxic chemotherapeutic agents, or other drugs that can cause neutropenia or significant nephrotoxicity. Rifampin or rifampin derivatives. Systemic antiinfectives. Required: At least 6 months of prior zidovudine. Active drug or alcohol abuse.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 1996</verification_date>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Antiviral Agents</keyword>
</DOC>